Replies to post #81731 on Biotech Values

[genisi]

Genentech/Biogen 2nd Generation Anti-CD20

I think you'll find the story here:

http://www.gene.com/gene/pipeline/status/immunology/ocrelizumab/

And the arbitration panel decision here:

http://www.gene.com/gene/news/gne_biib_arb.html